RCM
AMPE

RA Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

RA Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,419
Closed -$9.94M – 41
2013
Q3 		$9.94M Buy
+4,419
New +$8.55M 1.04% 25

Other funds holding AMPE

NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

RA Capital Management's AMPE Position: Q4 2013 in Review

RA Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2013, closing a stake of 4,419 shares — an estimated $9.94M sold.

RA Capital Management first reported a position in AMPE in Q3 2013 and held it in 1 quarter. The position peaked at $9.94M in Q3 2013. 59 funds tracked by Wall St. Rank hold AMPE as of Q4 2013.

  • RA Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2013 after selling out during the quarter.
  • RA Capital Management sold 4,419 Ampio Pharmaceuticals Inc. shares in Q4 2013, an estimated $9.94M.
  • RA Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 1 quarter.
  • RA Capital Management's Ampio Pharmaceuticals Inc. position peaked at $9.94M in Q3 2013.
  • 59 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2013.

Based on RA Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.